drugset / Trial / NCT04218773

Blood PREssure Augmentation in Large-vessel Occlusion Stroke Study

NCT04218773

Phase 0 Suspended 40 enrolled Yale University
NaSequentialOpen-labelTreatment

Summary

An open label, prospective, single center, pilot trial to assess feasibility and tolerability of short term blood pressure augmentation to minimize infarct progression in acute LVO stroke patients undergoing endovascular therapy.

Timeline

Start
2020-09-11
Primary completion
2026-08
Completion
2026-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Norepinephrine Other / unclassified 3 ug Intravenous
Subject Phenylephrine Small molecule 60 ug Intravenous